Filters
New
Hikma launches Cisatracurium Besylate Injection, USP in the US
Press Release, Product
25 March 2025
New
Hikma announces Health Canada approval of KLOXXADO® (naloxone HCl) Nasal Spray 8 mg
Press Release, Product
20 March 2025
New
Developing our pipeline in growing therapeutic areas
Story, Corporate
19 March 2025
New
Focusing on our quality manufacturing
Story, Corporate
19 March 2025
New
Expanding our patient reach across our markets
Story, Corporate
19 March 2025
New
Leveraging our role as a leading healthcare provider in MENA
Story, Corporate
19 March 2025
Providing access to clean water for families in Egypt
Story, Responsibility
19 March 2025
Supporting food banks for those in need
Story, Responsibility
19 March 2025
Hikma to host meet the management and site visit in Columbus, Ohio
Press Release, Corporate
17 March 2025
New
Hikma receives FDA approval and launches Mercaptopurine Oral Suspension in the US
Press Release, Product
27 February 2025
New
Strong 2024 performance and a positive outlook for 2025
Press Release, Financial Results
26 February 2025
Hikma and M42 sign strategic MOU to advance healthcare innovation in the UAE
Press Release, Business Development
30 January 2025
You have viewed 15 of 473 results